Some WHO-approved malaria drugs fall short: study

July 10, 2012

Up to eight percent of malaria drugs approved by the World Health Organization or other regulators do not contain the right dose and may fuel resistance, researchers said Tuesday.

Two studies in published in Research and Reports in suggested manufacturing problems, rather than counterfeiting, may be to blame for these substandard drugs in low and around the world.

Poorly made or fake medications are a major problem worldwide, particularly as signs emerge of growing resistance to artemisinin, the frontline treatment for malaria, a disease the UN's (WHO) says killed 655,000 people in 2010.

One study sampled 104 artemisinin-based medicines from pharmacies in Ghana and Nigeria that were offered under the Affordable Medicines Facility by the Global Fund to Fight AIDS, designed to boost access to the best treatments.

Eight were found to be significantly under-dosed in artemisinin, or had less than 75 percent of the main component of the drug, the study authors said.

"Why am I pretty sure that these are not fakes?" asked Roger Bate, lead author and resident scholar at the American Enterprise Institute.

"The reason is they have well over 50 percent of the active ingredient but under 75 percent," he said, adding that most counterfeits have very little or no in them.

A separate study that spanned 2,652 essential drugs -- including medicines for malaria, tuberculosis and bacterial infections -- found that the failure rate among WHO-approved products was 6.8 percent.

The samples came from 11 sites in Africa, three Indian cities, as well as Sao Paulo, Moscow, Bangkok, Istanbul and Beijing.

The highest failure rate -- 17.65 percent -- was seen among Chinese-made products approved by the WHO, said the study.

Researchers said the WHO has launched an investigation.

Explore further: Fake malaria drugs a growing problem: experts

Related Stories

Fake malaria drugs a growing problem: experts

December 5, 2011

Fake or poor quality malaria drugs are boosting resistance in parts of southeast Asia, a problem that is likely to worsen unless tighter regulations are adopted, US experts said Monday.

Fake malaria drugs threaten crisis in Africa

January 17, 2012

(Medical Xpress) -- The emergence of fake and poor quality anti-malarial drugs could dash hopes of controlling malaria in Africa, warn experts writing in the Malaria Journal. Millions of lives could be put at risk unless ...

WHO hopeful drug-resistant malaria can be contained

April 24, 2012

The World Health Organisation said Tuesday it was optimistic drug-resistant malaria that has emerged along Thailand's borders with Cambodia and Myanmar could be contained within the region.

Recommended for you

Why kicking the opioid habit can be so tough

July 20, 2016

(HealthDay)—He was 26, a specialist fifth class with the U.S. Army, and stationed abroad, when an accident on the German autobahn sent him careening through the windshield of his car.

New research shows vaccine protection against Zika virus

June 28, 2016

The rapid development of a safe and effective vaccine to prevent the Zika virus (ZIKV) is a global priority, as infection in pregnant women has been shown to lead to fetal microcephaly and other major birth defects. The World ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.